![Tiago Girão](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tiago Girão
Director of Finance/CFO at
IMMUNOVANT, INC.
Net worth: 9 M $ as of 31/07/2026
Profile
Tiago M.
Girão is currently Chief Financial Officer at Proteovant Therapeutics, Inc. and will be Chief Financial Officer at Immunovant, Inc. starting in 2025.
Former positions include Independent Director at Landos Biopharma, Inc. from 2021 to 2024; International Controller at NuVasive LLC from 2012 to 2014; Senior Manager at KPMG LLP from 2000 to 2004; Chief Financial Officer & Vice President at Plus Therapeutics, Inc. from 2014 to 2015; Senior Accountant at Ernst & Young Terco; Chief Financial Officer at Roivant Sciences, Inc.; and Chief Financial Officer & Senior VP-Operations at Cytori Therapeutics, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Fortaleza.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.12% | 23/07/2026 | 240,798 ( 0.12% ) | 9 M $ | 31/07/2026 |
| 25/07/2018 | 1 ( -.--% ) | 4 $ | 31/07/2026 |
Tiago Girão active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Director of Finance/CFO | 18/04/2025 |
Proteovant Therapeutics, Inc. | Director of Finance/CFO | - |
Former positions of Tiago Girão
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Board Member | 23/05/2024 |
| CERENOME, INC. | Director of Finance/CFO | 31/03/2019 |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Director of Finance/CFO | 01/03/2019 |
| NUVASIVE, INC. | Comptroller/Controller/Auditor | 01/08/2014 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/08/2004 |
Training of Tiago Girão
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Ernst & Young Terco
 Ernst & Young Terco Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Fortaleza
 University of Fortaleza Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Health Technology |
Proteovant Therapeutics, Inc. |
- Stock Market
- Insiders
- Tiago Girão
